Jacqueline L. Whatmore
Exeter, ENG EX12LU, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
STING-Triggered CNS Inflammation in Human Neurodegenerative Diseases.
Journal: Biomedicines
Published: March 10, 2023
The role of astrocytes in brain metastasis at the interface of circulating tumour cells and the blood brain barrier.
Journal: Frontiers in bioscience (Landmark edition)
Published: June 22, 2021
Hydrogen Sulfide Is a Novel Protector of the Retinal Glycocalyx and Endothelial Permeability Barrier.
Journal: Frontiers in cell and developmental biology
Published: June 14, 2021
Endoplasmic reticulum stress-induced release and binding of calreticulin from human ovarian cancer cells.
Journal: Cancer immunology, immunotherapy : CII
Published: July 28, 2020
Cathepsin D in the Tumor Microenvironment of Breast and Ovarian Cancers.
Journal: Advances in experimental medicine and biology
Published: June 25, 2020
Non-invasive measurement of retinal permeability in a diabetic rat model.
Journal: Microcirculation (New York, N.Y. : 1994)
Published: January 06, 2020
Microstructural Characterization of Resistance Artery Remodelling in Diabetes Mellitus.
Journal: Journal of vascular research
Published: September 30, 2019
Cathepsin L-induced galectin-1 may act as a proangiogenic factor in the metastasis of high-grade serous carcinoma.
Journal: Journal of translational medicine
Published: February 19, 2019
High Expression of Galectin-1, VEGF and Increased Microvessel Density Are Associated with MELF Pattern in Stage I-III Endometrioid Endometrial Adenocarcinoma.
Journal: Journal of pathology and translational medicine
Published: February 01, 2019
Locally delivered GLP-1 analogues liraglutide and exenatide enhance microvascular perfusion in individuals with and without type 2 diabetes.
Journal: Diabetologia
Published: January 23, 2019
Cathepsin L Induces Proangiogenic Changes in Human Omental Microvascular Endothelial Cells via Activation of the ERK1/2 Pathway.
Journal: Current cancer drug targets
Published: April 11, 2018
Last Updated: 09/26/2026